CDSCO recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for treatment of adult patients who have high risk of progression of the disease.
Amid the ongoing resurgence of new Covid-19 cases in the country, an expert panel of the Central Drugs Standard Control Organisation has approved two new vaccines and one anti-viral drug for restricted use in emergency situation.
Read more about Drug regulator CDSCO approves vaccines Corbevax, Covovax, anti-viral drug Molnupiravir for restricted emergency use against COVID-19 on Devdiscourse
An expert panel of the country's central drug authority has recommended granting Emergency Use Authorisation to Serum Institute's Covid vaccine 'Covovax' with certain conditions, official sources said on Monday.